RE: Director deals19 Feb 2021 18:52
@Jadam yes market will decide, various factors will come into play, non covid revenues for CD4 and food detective which should start to get traction in 21/22 plus allergy business should recover. These revenues will form the base, plus any developments that become visible in the next year or so. Re covid revenues nobody as yet knows what the legacy volumes will be in years to come, there will be some, how much is the question. Finally I do expect a dividend policy to be announced at some point in next 6 months, all these factors will impact the PE moving forward.